| Literature DB >> 30402343 |
Delmacia G de Macêdo1, Marta Maria A Souza1, Maria Flaviana B Morais-Braga1, Henrique Douglas M Coutinho2, Antonia Thassya L Dos Santos2, Rafael P da Cruz2, José Galberto M da Costa2, Fábio Fernandes G Rodrigues2, Lucindo J Quintans-Junior3, Jackson Roberto G da Silva Almeida4, Irwin Rose A de Menezes2.
Abstract
Medicinal plants play a crucial role in the search for components that are capable of neutralizing the multiple mechanisms of fungal resistance. Psidium salutare (Kunth) O. Berg is a plant native to Brazil used as both food and traditional medicine to treat diseases and symptoms such as stomach ache and diarrhea, whose symptoms could be related to fungal infections from the genus Candida. The objective of this study was to investigate the influence of seasonal variability on the chemical composition of the Psidium salutare essential oil, its antifungal potential and its effect on the Candida albicans morphogenesis. The essential oils were collected in three different seasonal collection periods and isolated by the hydrodistillation process in a modified Clevenger apparatus with identification of the chemical composition determined by gas chromatography coupled to mass spectrometry (GC/MS). The antifungal assays were performed against Candida strains through the broth microdilution method to determine the minimum fungicidal concentration (MFC). Fungal growth was assessed by optical density reading and the Candida albicans dimorphic effect was evaluated by optical microscopy in microculture chambers. The chemical profile of the essential oils identified 40 substances in the different collection periods with γ-terpinene being the predominant constituent. The antifungal activity revealed an action against the C. albicans, C. krusei and C. tropicalis strains with an IC50 ranging from 345.5 to 2,754.2 µg/mL and a MFC higher than 1,024 µg/mL. When combined with essential oils at sub-inhibitory concentrations (MIC/16), fluconazole had its potentiated effect, i.e. a synergistic effect was observed in the combination of fluconazole with P.salutare oil against all Candida strains; however, for C. albicans, its effect was reinforced by the natural product in all the collection periods. The results show that the Psidium salutare oil affected the dimorphic transition capacity, significantly reducing the formation of hyphae and pseudohyphae in increasing concentrations. The results show that P. salutare oil exhibits a significant antifungal activity against three Candida species and that it can act in synergy with fluconazole. These results support the notion that this plant may have a potential use in pharmaceutical and preservative products.Entities:
Keywords: Candida sp.; Chemical composition; Micromorphology; Morphogenesis; Pathogenesis; Precipitation; Seasonal variation; γ-terpinene
Year: 2018 PMID: 30402343 PMCID: PMC6215697 DOI: 10.7717/peerj.5476
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
The average annual of meteorological conditions for each collection (2016).
| Collection period | February | May | August | 2016 Average annual |
|---|---|---|---|---|
| OEFPs1/ winter | OEFPs2/ winter | OEFPs3/ summer | ||
| Precipitation (mm) | 49 | 145 | 0.0 | 968.0 |
| Yield (%) | 0.73 | 0.29 | 0.15 | |
| Temperature (°C) | 26 | 27 | 35 |
Notes.
essential oil of Psidium salutare sheets, 1, 2, 3 collection
Determination of the percentage composition of the chemical composition of the Psidium salutare leaf essential oil by gas chromatography coupled to mass spectrometry (CG/MS) in different collection periods.
| Compounds | tR* (min) | OEFPs1 | OEFPs2 | OEFPs3 | % (media) |
|---|---|---|---|---|---|
| 1,8 Cineole | 5.5 | 0.61a | 0.51a | 1.05a | 0.72 |
| Dimethyl benzylcarbinyl acetate | 8.2 | 0.19a | 0.15a | 0.65a | 0.33 |
| Copaene | 11.2 | 3.22a | 3.53a | 1.91a | 2.89 |
| Cubenol | 14.8 | 0.63a | 0.0a | 3.42a | 1.35 |
| Espatulenol | 12.2 | 0.23a | 0.30a | 0.13a | 0.22 |
| Sabinene hydrate | 8.1 | 2.28a | 3.48a | 3.94a | 3.23 |
| Isocarofilene | 11.9 | 3.78a | 3.75a | 1.20a | 2.91 |
| Limonene | 5.4 | 1.10a | 1.15a | 1.14a | 1.13 |
| Linalool | 6.6 | 5.55a | 4.72a | 7.26a | 5.84 |
| Myrcene | 4.7 | 0.65a | 0.42a | 0.08b | 0.38 |
| Myrtenol | 7.5 | 0.21a | 0.16a | 0.09a | 0.15 |
| Ocimene | 5.7 | 2.15a | 1.93a | 1.50a | 1.86 |
| Palustrol | 14.1 | 0.05a | 0.11a | 0.10a | 0.09 |
| Patchoulane | 14.7 | 0.25a | 0.19a | 3.08a | 1.17 |
| P-Cymene | 5.3 | 5.05b | 6.37b | 17.83e | 9.75 |
| Selina-3,7 (11) -diene | 13.6 | 0.37a | 0.28a | 0.0a | 0.22 |
| Seychellene | 13.9 | 0.20a | 0.17a | 0.40a | 0.26 |
| Terpineol | 8.3 | 1.67a | 0.90a | 0.12a | 0.90 |
| Terpinolene | 6.4 | 16.99c | 14.49c | 6.90b | 12.79 |
| Valencene | 13.3 | 0.23a | 0.09a | 0.30a | 0.21 |
| Viridiflorene | 16.4 | 0.12a | 0.0a | 0.35a | 0.16 |
| Viridiflorol | 14.7 | 0.53a | 0.95a | 2.07a | 1.18 |
| α-phellandrene | 5.0 | 0.15a | 0.08a | 0.05a | 0.09 |
| α-caryophyllene | 12.4 | 0.24a | 0.29a | 1.68a | 0.74 |
| α-cubebene | 15.0 | 0.90a | 2.05a | 0.0a | 0.98 |
| α-farnesene | 13.8 | 0.03a | 0.03a | 0.24a | 0.10 |
| α-gurjunene | 11.7 | 0.21a | 0.10a | 0.08a | 0.13 |
| α-muurolene | 12.6 | 0.63a | 0.72a | 0.69a | 0.68 |
| α-pinene | 5.1 | 0.83a | 0.55a | 0.62a | 0.67 |
| β-cadinene | 5.9 | 0.96a | 1.45a | 0.83a | 1.08 |
| β-elemene | 13.7 | 0.16a | 0.12a | 0.70a | 0.33 |
| β-eudesmene | 12.8 | 0.15a | 0.11a | 0.0a | 0.09 |
| β-guaienum | 15.5 | 2.79a | 3.12a | 0.0a | 1.97 |
| γ-gurjunene | 13.6 | 0.10a | 0.21a | 0.26a | 0.19 |
| γ-muurolene | 13.2 | 2.58a | 2.42a | 3.20a | 2.73 |
| γ-terpinene | 5.9 | 13.97d | 17.09d | 10.32c | 13.79 |
| δ-cadinene | 13.3 | 5.27a | 3.88a | 3.84a | 4.33 |
| δ-cadinol | 15.3 | 1.68a | 0.0a | 0.92a | 0.87 |
| δ-guaiene | 14.9 | 0.28a | 0.28a | 3.70b | 1.42 |
| τ-cadinol | 15.2 | 12.75d | 10.51d | 10.35d | 11.20 |
| Monotherpenes hydrocarbons | 40.06 | 41.53 | 37.82 | 39.79 | |
| Sesquiterpenes hydrocarbons | 21.65 | 22.15 | 18.98 | 20.94 | |
| Oxygenated monotherpenes | 11.15 | 10.32 | 13.08 | 12.98 | |
| Oxygenated sesquiterpenes | 15.87 | 11.87 | 16.99 | 14.91 | |
| Others | 1.01 | 0.79 | 4.13 | 1.44 | |
| Total | 89.74 | 86.66 | 91.00 | 90.6 |
Notes.
retention time
essential oil from the leaves of Psidium salutare; first collection (February), second collection (May), third collection (August). Averages followed by different letters differ by Tukey test at p < 0.05
The inhibitory effect of association the essential oil of P. salutare with fluconazole on Candida (µg/mL).
| Tested Products | Strains | |||||
|---|---|---|---|---|---|---|
| CA INCQS 40006 | CT INCQS 40042 | CK INCQS 40095 | ||||
| CFM µg/mL | IC50 µg/mL | CFM µg/mL | IC50 µg/mL | CFM µg/mL | IC50 µg/mL | |
| Fluconazole (FCZ) | 8,192 | 16.8 | ≥16,384 | 9.3 | ≥16,384 | 271 |
| OEFPs 1+FCZ | 1,024 | 2.7 | ≥16,384 | 2.6 | 8,192 | 44.4 |
| OEFPs 2+FCZ | 8,192 | 8.0 | ≥16,384 | 5.3 | 1,024 | 32.4 |
| OEFPs 3+FCZ | 4,096 | 6.3 | ≥16,384 | 3.7 | 8,192 | 45.2 |
Notes.
essential oil of Psidium salutare leaves, 1, 2 and 3 collections
Candida albicans
Candida tropicalis
Candida krusei
National Institute of Health Quality Control
the inhibitor concentration that decreases 50% of the growth
Figure 1Cell viability curve and IC50 of the P. salutare essential oil (A, C and E) and the oil in combined with fluconazole (B, D and F) against different Candida spp. strains, at different collection periods.
Concentration of fluconazole: 2,048 µg/mL. OEFPs, Essential oil of the leaves of Psidium salutare, 1, 2 and 3 collections; CA, C. albicans; CT, C. tropicalis; CK, C. krusei; INCQS, National Institute of Quality Control in Health. (A) Cell viability curve and IC50 of Psidium salutare essential oil against Candida albicans. (B) Cell viability curve and IC50 of Psidium salutare essential oil combined with fluconazole against Candida albicans. (C) Cell viability curve and IC50 of Psidium salutare essential oil against Candida tropicalis. (D) Cell viability curve and IC50 of Psidium salutare essential oil combined with fluconazole against Candida tropicalis. (E) Cell viability curve and IC50 of Psidium salutare essential oil against Candida krusei. (F) Cell viability curve and IC50 of Psidium salutare essential oil combined with fluconazole against Candida krusei.
The CFM (µg/mL) of the essential oil of P. salutare on different strains of Candida in modulatory effect.
| OEFPs1 µg/mL | OEFPs1+FCZ µg/mL | OEFPs2 µg/mL | OEFPs2+FCZ µg/mL | OEFPs3 µg/mL | OEFPs3+FCZ µg/mL | |
|---|---|---|---|---|---|---|
| CA INCQS 40006 | 1,024 | 581.3 | 8,192 | 1,709.3 | 4,096 | 1,547.1 |
| CT INCQS 40042 | ≥16,384 | 2,570.4 | ≥16,384 | 2,754.2 | ≥16,384 | 1,621.8 |
| CK INCQS 40095 | 8,192 | 1,621.8 | 1,024 | 345.5 | 8,192 | 1,949.8 |
Notes.
essential oil of leaves of P. salutare, 1,2 and 3 collections
C. albicans
C. tropicalis
C. krusei
National Institute of Quality Control in Health
Figure 2Effect of the Psidium salutare essential oil on Candida albicans yeast micromorphological aspects.
Culture performed in depleted potato dextrose agar medium, with 40×objective visualization. (A) Growth control, (B) fluconazole antifungal effect at 2,048 µg/mL, (C) P. salutare essential oil effect at 8,192 μg/mL, (D) P. salutare essential oil effect at 2,048 µg/mL and (E) (C) P. salutare essential oil effect at 512 µg/mL; CA, C. albicans; INCQS, National Institute of Quality Control in Health.